Alkoxylation methods

Patent metadata

Field	Value
Publication number	US-11834553-B2
Application number	US-202017062457-A
Country	US
Kind code	B2
Filing date	Oct 2, 2020
Priority date	Nov 18, 2009
Publication date	Dec 5, 2023
Grant date	Dec 5, 2023

Abstract

Among other aspects, provided herein is a mixed-acid salt of a water-soluble polymer-drug conjugate, along with related methods of making and using the same. The mixed-salt acid salt is stably formed, and appears to be more resistant to hydrolytic degradation than the corresponding predominantly pure acid salt or free base forms of the polymer-drug conjugate. The mixed acid salt is reproducibly prepared and recovered, and provides surprising advantages over non-mixed acid salt forms of the water-soluble polymer drug conjugate.

First claim

What is claimed is:

1. A method of preparing a highly pure reactive multi-armed polyethylene glycol reagent suitable for use in preparing a pharmaceutical conjugate, the method comprising:
(a) providing a previously isolated alkoxylatable oligomer having a structure:

and a weight average molecular weight of from 300 daltons to 5,000 daltons, wherein the value of each n is substantially the same;
(b) alkoxylating the isolated alkoxylatable oligomer from step (a) in an aprotic, substantially anhydrous organic solvent in the presence of from 0.01 to about 6.0 weight percent of a strong base by sequential addition of oxirane (ethylene oxide) under anhydrous liquid phase conditions of less than 20 ppm water and in an amount effective to form a reaction mixture comprising an alkoxylated polymeric product having a weight-average molecular weight of from about 6,000 daltons to about 80,000 daltons,
(c) recovering from the reaction mixture the alkoxylated polymeric product, wherein the recovered alkoxylated polymeric product has a purity of greater than 92 weight percent, and
(d) forming a reactive water-soluble multi-armed polyethylene glycol reagent by transforming the recovered alkoxylated polymeric product to bear reactive groups suitable for conjugation with a biologically active agent.

2. The method of claim 1 , wherein the isolated alkoxylatable oligomer has a known and defined weight-average molecular weight from 500 daltons to 3,000 daltons.

3. The method of claim 1 , wherein both the isolated alkoxylatable oligomer and the alkoxylated polymeric product are soluble in the aprotic, substantially anhydrous organic solvent.

4. The method of claim 1 , wherein all values of n in step (a) are within three standard deviations of each other, and all values of (n) in step (b) are within three standard deviations of each other.

5. The method of claim 4 , wherein all values of n in step (a) are within two standard deviations of each other, and all values of (n) in step (b) are within two standard deviations of each other.

6. The method of claim 1 , wherein the aprotic, substantially anhydrous organic solvent is selected from the group consisting of toluene, xylene, mesitylene, tetrahydrofuran (THF), and mixtures of foregoing.

7. The method of claim 1 , where in step (b), the aprotic, substantially anhydrous organic solvent is toluene, present in an amount that is more than 25 weight percent and less than 75 weight percent of the reaction mixture based on the weight of the reaction mixture following the complete addition of the oxirane.

8. The method of claim 1 , wherein the strong base is selected from the group consisting of alkali metals, hydroxides, and an alkoxides.

9. The method of claim 8 , wherein the strong base is selected from metallic potassium, metallic sodium, sodium-potassium alloys, sodium hydroxide, and potassium hydroxide.

10. The method of claim 1 , wherein the strong base is present in a catalytic amount.

11. The method of claim 1 , wherein the alkoxylating step is carried out at a temperature between 50° C. and 200° C.

12. The method of claim 1 , wherein the alkoxylated polymeric product has a weight-average molecular weight of from about 10,000 daltons to about 40,000 daltons.

13. The method of claim 1 , wherein the reactive multi-armed polyethylene glycol reagent comprises reactive groups selected from carboxylic acid, active ester, amine, thiol, maleimide and aldehyde.

14. The method of claim 13 , wherein the reactive multi-armed polyethylene glycol reagent comprises reactive N-hydroxysuccinimidyl ester groups.

15. The method of claim 1 , further comprising contacting, under conjugation conditions, a biologically active agent with the reactive water-soluble multi-armed polyethylene glycol reagent from step (d).

16. The method of claim 1 , wherein the recovered alkoxylated polymeric product from step (c) has a purity of greater than 97 weight percent.

Assignees

• Nektar Therapeutics

Inventors

• Kozlowski Antoni
• Mcmanus Samuel P
• Tipnis Sachin
• Lavaty Greg
• Swallow David
• Handley John R
• Schaefer Anthony G

Classifications

• C08G65/331 Primary

  containing oxygen {(cyclic ether compounds C08G65/26)} · CPC title

• A61K31/4745 Primary

  condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines (yohimbine derivatives, vinblastine A61K31/475; ergoline derivatives A61K31/48) · CPC title

• A61K47/60 Primary

  the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol · CPC title

• C07C51/412

  by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part · CPC title

• C07C53/18

  containing fluorine · CPC title